• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耶氏肺孢子菌和曲霉菌合并感染患者院内死亡的临床特征及危险因素

Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus.

作者信息

Zhong Yuxia, Ji Ting, Qin Dan, Cheng Deyun

机构信息

Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Sichuan 610041, China.

Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Sichuan 610041, China.

出版信息

J Mycol Med. 2023 Mar;33(1):101330. doi: 10.1016/j.mycmed.2022.101330. Epub 2022 Sep 8.

DOI:10.1016/j.mycmed.2022.101330
PMID:36265259
Abstract

OBJECTIVE

To analyze clinical characteristics and risk factors for in-hospital mortality in patients coinfected with P. jirovecii and Aspergillus.

METHODS

This study included 53 patients with coinfection of P. jirovecii pneumonia (PJP) and invasive pulmonary aspergillosis (IPA) in our center from January 2011 to December 2021. All cases were divided into survivor (n=27) and non-survivor groups (n=26). Medical records, laboratory and radiology data were collected. Risk factors for in-hospital mortality were identified by multivariable analyses.

RESULTS

HIV-positive patients accounted for 3.8%. Fever (77.4%), dyspnea (69.8%) and wet cough (24.5%) were common symptoms. Ground-glass opacity (83.0%), consolidation (71.7%), septal thickening (66.0%), and nodules (54.7%) were the most common radiological signs. CD4+ T cell count and serum albumin (ALB) level were significantly lower in non-survival group than in the survival group. Conversely, serum lactate dehydrogenase (LDH) and procalcitonin (PCT) levels were higher in non-survival group than in survival group. Lactic acidosis [odds ratio (OR): 33.999,95% confidential interval (CI): 3.112-371.409; p=0.004], low CD4+ T cell count (<114 cell/µL) [OR: 19.343, 95% CI: 1.533-259.380; p=0.022] and high level of LDH (> 519 U/L) [OR: 11.422, 95% CI: 1.271-102.669; p=0.030] were independent risk factors for mortality.

CONCLUSION

PJP coinfected with IPA incurs high mortality with nonspecific clinical characteristics and is more likely to involve HIV-negative patients. Lactic acidosis, low CD4+ T cell count and high LDH level are independent risk factors for mortality, close monitoring of these parameters is necessary to help distinguish high-risk patients and make appropriate clinical decisions.

摘要

目的

分析耶氏肺孢子菌和曲霉合并感染患者的临床特征及院内死亡的危险因素。

方法

本研究纳入了2011年1月至2021年12月在本中心的53例耶氏肺孢子菌肺炎(PJP)和侵袭性肺曲霉病(IPA)合并感染患者。所有病例分为存活组(n = 27)和非存活组(n = 26)。收集病历、实验室和影像学数据。通过多变量分析确定院内死亡的危险因素。

结果

HIV阳性患者占3.8%。发热(77.4%)、呼吸困难(69.8%)和湿性咳嗽(24.5%)是常见症状。磨玻璃影(83.0%)、实变(71.7%)、小叶间隔增厚(66.0%)和结节(54.7%)是最常见的影像学表现。非存活组的CD4 + T细胞计数和血清白蛋白(ALB)水平显著低于存活组。相反,非存活组的血清乳酸脱氢酶(LDH)和降钙素原(PCT)水平高于存活组。乳酸酸中毒[比值比(OR):33.999,95%置信区间(CI):3.112 - 371.409;p = 0.004]、低CD4 + T细胞计数(<114个细胞/μL)[OR:19.343,95% CI:1.533 - 259.380;p = 0.022]和高水平的LDH(>519 U/L)[OR:11.422,95% CI:1.271 - 102.669;p = 0.030]是死亡的独立危险因素。

结论

PJP合并IPA死亡率高,临床特征不特异,且更易累及HIV阴性患者。乳酸酸中毒、低CD4 + T细胞计数和高LDH水平是死亡的独立危险因素,密切监测这些参数有助于区分高危患者并做出适当的临床决策。

相似文献

1
Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus.耶氏肺孢子菌和曲霉菌合并感染患者院内死亡的临床特征及危险因素
J Mycol Med. 2023 Mar;33(1):101330. doi: 10.1016/j.mycmed.2022.101330. Epub 2022 Sep 8.
2
Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?COVID-19 与 PJP 关系的叙述性综述:它代表合并感染还是定植?
Infection. 2021 Dec;49(6):1079-1090. doi: 10.1007/s15010-021-01630-9. Epub 2021 May 31.
3
Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.伴有和不伴有人类免疫缺陷病毒感染患者的耶氏肺孢子菌肺炎
J Microbiol Immunol Infect. 2008 Dec;41(6):478-82.
4
Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.儿童肺孢子菌肺炎。单个中心三十年回顾性研究。
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Mar;38(3):111-118. doi: 10.1016/j.eimc.2019.05.005. Epub 2019 Jul 1.
5
Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.非HIV免疫功能低下患者中与耶氏肺孢子菌肺炎相关的危险因素及宏基因组下一代测序对共病原体的分析
BMC Pulm Med. 2023 Feb 24;23(1):72. doi: 10.1186/s12890-022-02300-8.
6
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.耶氏肺孢子菌肺炎诊断时呼吸道合并感染的流行病学及临床影响
J Infect Dis. 2022 Mar 2;225(5):868-880. doi: 10.1093/infdis/jiab460.
7
Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.一名免疫功能低下患者并发耶氏肺孢子菌和侵袭性肺曲霉病:诊断挑战
Onkologie. 2013;36(10):582-4. doi: 10.1159/000355168. Epub 2013 Sep 16.
8
Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.单中心回顾性分析肾移植术后患者肺部卡氏肺孢子虫肺炎。
Transpl Immunol. 2022 Jun;72:101593. doi: 10.1016/j.trim.2022.101593. Epub 2022 Apr 5.
9
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.无需对接受抗逆转录病毒治疗(ART)后病毒血症得到抑制且 CD4 细胞计数大于 100 个/µL 的欧洲成人 HIV 感染者进行继发性卡氏肺孢子菌肺炎预防。
J Int AIDS Soc. 2021 Jun;24(6):e25726. doi: 10.1002/jia2.25726.
10
Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study.肺孢子菌肺炎在 AIRD 患者中的特征及相关危险因素:一项回顾性研究。
Rheumatology (Oxford). 2022 Aug 30;61(9):3766-3776. doi: 10.1093/rheumatology/keab941.

引用本文的文献

1
Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of infection in patients with lung cancer.纳米孔宏基因组第三代测序在肺癌患者感染诊断中的诊断价值
J Med Microbiol. 2025 Jul;74(7). doi: 10.1099/jmm.0.002031.
2
Development of a Prognostic Nomogram for Nonneutropenic Invasive Pulmonary Aspergillosis Based on Machine Learning.基于机器学习的非中性粒细胞减少侵袭性肺曲霉病预后列线图的开发
J Inflamm Res. 2024 Nov 26;17:9823-9835. doi: 10.2147/JIR.S499008. eCollection 2024.
3
Development of a Multiplex Real-Time PCR Assay for the Simultaneous Detection of Two Fungal Pathogens Causing Pneumonia.
用于同时检测两种引起肺炎的真菌病原体的多重实时荧光定量PCR检测方法的开发
J Fungi (Basel). 2024 Aug 29;10(9):619. doi: 10.3390/jof10090619.
4
Distribution of species and risk factors for aspergillosis in mainland China: a systematic review.中国大陆曲霉病的物种分布及危险因素:一项系统综述
Ther Adv Infect Dis. 2024 Jun 4;11:20499361241252537. doi: 10.1177/20499361241252537. eCollection 2024 Jan-Dec.
5
Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study.使用数字读取器的曲霉半乳甘露聚糖侧流分析用于诊断侵袭性曲霉病的性能:一项多中心研究。
Eur J Clin Microbiol Infect Dis. 2024 Feb;43(2):249-257. doi: 10.1007/s10096-023-04724-4. Epub 2023 Nov 29.
6
Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza.新型冠状病毒肺炎(COVID-19)或流感重症患者中呼吸机相关性肺炎(VAP)的死亡率、发病率及微生物学记录
Ann Intensive Care. 2023 Oct 30;13(1):108. doi: 10.1186/s13613-023-01207-9.
7
Invasive pulmonary co-infection caused by sp. and , complicated by reactivation in a patient following second allogeneic hematopoietic stem cell transplantation - Case report.由[具体菌种1]和[具体菌种2]引起的侵袭性肺部合并感染,在一名接受第二次异基因造血干细胞移植的患者中并发[某种疾病]再激活——病例报告
Med Mycol Case Rep. 2023 Oct 11;42:100613. doi: 10.1016/j.mmcr.2023.100613. eCollection 2023 Dec.
8
Epidemiology and antifungal susceptibilities of clinically isolated species in South China.中国南方临床分离真菌种的流行病学和抗真菌药敏性。
Epidemiol Infect. 2023 Oct 17;151:e184. doi: 10.1017/S095026882300167X.
9
Changing Trends in the Incidence and Clinical Features of Pneumonia in Non-HIV Patients before and during the COVID-19 Era and Risk Factors for Mortality between 2016 and 2022.2016年至2022年间,非HIV患者在COVID-19大流行之前和期间肺炎发病率及临床特征的变化趋势以及死亡风险因素
Life (Basel). 2023 Jun 7;13(6):1335. doi: 10.3390/life13061335.